Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Российский университет дружбы народов, Москва
Список исп. литературыСкрыть список 1. Акжигитов Р.Г., Яковлев А.Ю. Клинический случай биполярной мании: трудности диагностики, возможности терапии и профилактики. Обозрение психиатрии и мед. психологии им. В.М.Бехтерева. 2011; 3: 43–7. 2. Клиническая психиатрия. Под ред. Т.Б.Дмитриевой. М., 1998. 3. Медведев В.Э. Кветиапин при терапии биполярного аффективного расстройства. Психиатр. и психофармакотер. 2010; 5: 14–9. 4. Психический тезаурус. Психические расстройства и расстройства поведения (F00-F99). Класс V МКБ-10, адаптированный в РФ. СПб., 2003. 5. Akiskal HS. Searching for behavioral indicators of bipolar II in patients with major depressive episodes: the «red sign», the «rule of three» and other biographic signs of temperamental extravagance, activation and hypomania. J Affect Disord 2005; 84: 279–90. 6. Akiskal HS. The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacol Bull 2007; 40: 99–115. 7. Akiskal HS, Bourgeois ML et al. Re-evaluating tile prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 1: 5–30. 8. American Psychiatric Association: practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiat 2002; 159. 9. Angst J, Baastrup P, Grof P et al. The course of monopolar depression and bipolar psychosis. Psychiatr, Neurol, neurochirurg 1973; 76: 486–500. 10. Angst J, Cui L, Swendsen J et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey replication. Am J Psychiat 2010; 167: 1194–201. 11. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord 2000; 2: 3–7. 12. Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000; 61 (1–2): 13–22. 13. Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience 2009; 164: 331–43. 14. Bauer M, Adli M, Bschor T et al. Lithium’s emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiol 2010; 62: 36–42. 15. Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiat 2004; 19: 85–90. 16. Bipolar disorder. Treatment recommendations for patients with bipolar disorder. Am J Psychiat 2002; 159 (4): 4–36. 17. Birmaher B, Axelson D, Strober M et al. Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders. Bipolar Disord 2009; 11: 52–62. 18. Bowden CL, Calabrese R et al. А randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiat 2000; 57: 481–9. 19. Calabrese JR, Shelton MD et al. A 20-mouth, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiat 2005; 11: 2152–61. 20. Canuso CM, Turkoz I, Fu DJ et al. Role of paliperidone extended-release in treatment of schizoaffective disorder. Neuropsychiatr Dis Treat 2010; 6: 667–79. 21. Cassano GB, Rucci P, Frank E et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiat 2004; 161: 1264–9. 22. Cicchetti D. Resilience under conditions of extreme stress: a multilevel perspective. World Psychiat 2010; 9: 145–54. 23. Chou Y-H, Wang S-J, Lin C-L et al. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disord 2010; 12: 312–8. 24. Correll CU. Understanding schizoaffective disorder: from psychobiology to psychosocial functioning. J Clin Psychiat 2010; 71: 8–13. 25. Cruz N, Sanchez-Moreno J, Torres F et al. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol 2010; 13: 5–14. 26. Esquirol JE. Mental Maladies: Treatise on Insanity. Philadelphia 1845. 27. Falret JP. Mémoire sur la folie circulaire, forme de la maladie mentale caractérisée par la reproduction … Bulletin de l\'Académie impériale de medicine. Paris 1854; 19: 382–400. 28. Ferrier IN. Developments in mood stabilisers. Br Med Bull 2001; 57: 179–92. 29. Gershon ES, Hamovit J, Guroff JJ et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiat 1982; 39 (10): 1157–67. 30. Ghaemi SN, Soldani F. Meta-analysis of observational studies: the case of rapid-cycling bipolar disorder. Acta Psychiat Scand 2003; 108 (1): 1–3. 31. Glatzel J. Hearing of voices during cyclothymic-depressive syndrome. Wien Z Nervenheilkd Grenzgeb 1973; 31 (1): 12–26. 32. Goldberg DP, Andrews G, Hobbs MJ. Where should bipolar disorder appear in the meta-structure? Psychol Med 2009; 39: 2071–81. 33. Goodwin GM. (Consensus Group of the British Association for Psychopharmacology): Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17: 149–73. 34. Goodwin G, Sachs G. Bipolar disorder. Oxford 2004. 35. Griesinger W. Mental pathology and theraprutics. Ed. J.Rutherford. NY 1855. 36. Ha TH, Ha K, Kim JH et al. Regional brain gray matter abnormalities in patients with bipolar II disorder: a comparison study with bipolar I patients and healthy controls. Neurosci Lett 2009; 456: 4–48. 37. Hirschfeld RM. Practice guideline for the treatment of patients with bipolar disorder. 2nd ed. American Psychiatric Association 2005. 38. Hirschfeld RM, Holzer C, Calabrese JR et al. Validity of the mood disorder questionnaire: a general population study. Am J Psychiat 2003; 160: 178–80. 39. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: reanalysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73: 123–31. 40. Janicak PG, Keck PE Jr, Davis JM et al. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. J Clin Psychopharmacol 2001; 21: 360–8. 41. Kaplan HI, Sadock BJ. Pocket handbook of clinical psychiatry. Williams & Wilkins 1996. 42. Klerman GL. The spectrum of mania. Compr Psychiat 1981; 22 (1): 11–20. 43. Kraepelin E. Manic-Depressive illness and paranoia. R.Barclay (trans) in G.Robertson. Edinburgh. E&S Livingstone 1921. 44. Leonhard K. Auftelling der endogenen psychosen. Berlin 1957. 45. Lynch TR, Trost WT, Salsman N et al. Dialectical behavior therapy for borderline personality disorder. Ann Rev Clin Psychol 2007; 3: 181–205. 46. Maj M, Pirozzi R, Magliano L et al. Agitated «unipolar» major depression: prevalence, phenomenology, and outcome. J Clin Psychiat 2006; 67: 712–9. 47. Manning JS. Difficult-to-treat depressions: a primary care perspective. J Clin Psychiat 2003; 64: 24–31. 48. Manning JS, Haykal RF, Akiskal HS. The role of bipolarity in depression in the family practice setting. Psychiatr Clin North Am 1999; 22: 689–703. 49. McElroy SL et al. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. J Clin Psychiat 2004; 2: 204–10. 50. McElroy SL, Frye MA, Hellemann G et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord 2011; 128: 191–8. 51. McElroy SL, Keck PE Jr, Strakowski SM. An overview of the treatment of schizoaffective disorder. J Clin Psychiat 1999; 5: 16–21. 52. McGuffin P, Rijsdijk F, Andrew M et al. The heritability of bipolar affective disorder and genetic relationship to unipolar depression. Arch Gen Psychiat 2003; 60: 497–502. 53. Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord 2009; 23: 156–74. 54. Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiat 2007; 64: 543–52. 55. Montgomery SA et al. Pharmacotherapy of depression and mixed states in bipolar disorder. J of affective disorders 2000; 59 (1): 39–56. 56. Narrow WE, Rae DS, Robins LN et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys’ estimates. Arch Gen Psychiat 2002; 59: 115–23. 57. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nature Neurosci 2010; 13: 1161–9. 58. Nurnberger JI Jr. A simulated genetic structure for bipolar illness. Am J Med Genet B Neuropsychiat Genet 2008; 147 (B): 952–6. 59. Nurnberger JI Jr, Berrettini W. Psychiatric genetics. In: M.Ebert, P.Loosen, B.Nurcombe et al (eds). Current diagnosis and treatment. 2nd ed. NY: McGraw Hill. Psychiat 2008; p. 15–34. 60. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007; 33: 905–11. 61. Parens E, Johnston J. Controversies concerning the diagnosis and treatment of bipolar disorder in children. Child and Adolescent Psychiat and Mental Health 2010; 4: 9. 62. Paris J. The bipolar spectrum: a critical perspective. Harv Rev Psychiat 2009; 17: 206–13. 63. Parker GB, Malhi GS, Crawford JG et al. Identifying «paradigm failures» contributing to treatment-resistant depression. J Affect Disord 2005; 87: 185–91. 64. Patten SB, Paris J. The bipolar spectrum – a bridge too far? Can J Psychiat 2008; 53: 762–8. 65. Perlis RH, Uher R, Ostacher M et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiat 2011; 68 (4): 351–60. 66. Perugi G, Toni C, Travierso MC et al. The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderline-bipolar II connection. J Affect Disord 2003; 73: 87–98. 67. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am 2002; 25: 713–37. 68. Phelps J, Angst J, Katzow J et al. Validity and utility of bipolar spectrum models. Bipolar Disord 2008; 10: 179–93. 69. Pinel P. A Treatise on Insanity. Cadell and Davies. London 1806. 70. Prakash O, Kumar CN, Shivakumar PT et al. Clinical presentation of mania compared with depression: data from a geriatric clinic in India. Int Psychogeriat 2009; 21: 764–7. 71. Ruggero CJ, Zimmerman M, Chelminski I et al. Borderline personality disorder and the misdiagnosis of bipolar disorder. J Psychiatr Res 2010; 44: 405–8. 72. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711–22. 73. Sato T, Bottlender R, Schröter A et al. Frequency of manic symptoms during a depressive episode and unipolar «depressive mixed state» as bipolar spectrum. Acta Psychiat Scand 2003; 107: 268–74. 74. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord 2008; 10: 245–55. 75. Smith DJ, Muir WJ, Blackwood DH. Is borderline personality disorder part of the bipolar spectrum? Harv Rev Psychiat 2004; 12: 133–9. 76. Sole B, Martinez-Aran A, Torrent C et al. Are bipolar II patients cognitively impaired: a systematic review. Psychol Med 2011; 41 (9): 1791–803. 77. Strakowski SM, Fleck DE, Maj M. Broadening the diagnosis of bipolar disorder: benefits vs risks. World Psychiat 2011; 10: 181–7. 78. Suppes T, Dennehy EB et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiat 2005; 66 (7): 870–86. 79. Swann AC, Bowden CL et al. Depression during mania. Arch Gen Psychiat 1997; 54: 37–42. 80. Taylor Tavares JV, Clark L, Cannon DM et al. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II disorder. Biol Psychiat 2007; 62: 917–24. 81. Zimmermann P, Brückl T, Nocon A et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiat 2009; 66: 1341–52. 82. Zimmerman M, Ruggero CJ, Chelminski I et al. Clinical characteristics of depressed outpatients previously overdiagnosed with bipolar disorder. Compr Psychiat 2010; 51: 99–105. 83. Zimmerman M, Ruggero CJ, Chelminski I et al. Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiat 2010; 71: 26–31.